Connecting, engaging and nurturing EMBL’s global community of current and former scientists, technicians, communicators and administrators
Three EMBL alumnae – Melina Schuh, Ângela Gonçalves, and Angela Relógio – have been recognised for pioneering work that is redefining how science understands women’s health, ageing, fertility, and personalised medicine.
Melina Schuh (EMBL Heidelberg predoc, Ellenberg Group, 2004–2008) has been awarded Falling Walls’ 2025 Science Breakthrough of the Year in Life Sciences Award for her team’s achievement in filming the entire ovulation process in real time.
Director of the Max Planck Institute for Multidisciplinary Sciences (MPI NAT) in Göttingen, Schuh was selected from 240 global nominations.
Using advanced live-cell microscopy, her team captured ovulation in isolated mouse follicles, revealing that the process occurs in three distinct phases: follicle expansion, contraction, and release. The findings open new avenues for fertility research and deepen understanding of how healthy eggs develop.
Speaking to MPI NAT, she said: “It has always been my dream to make the entire ovulation process visible. This award is a great honour and a motivation to keep asking bold questions and finding new ways to answer them.”
Ângela Gonçalves (EMBL-EBI predoc, Brazma Group, 2008–2013) is one of three winners of the Falling Walls Foundation’s 2025 Women’s Impact Award. One winner will be named Science Breakthrough of the Year in the Women’s Impact category and present their work on stage at the Falling Walls Science Summit in Berlin on 9 November.
Now a Professor at Heidelberg University and Group Leader at the German Cancer Research Center (DKFZ), Gonçalves has been recognised for her project “How the biological clock ticks in the female reproductive tract: the influence of reproductive cycling on ageing and disease.”
Her research combines AI, molecular biology, and clinical insight to develop non-invasive tools for the early detection and prevention of conditions such as endometriosis, ovarian cancer, and menopause-related disorders.
“Biomedical science has historically centred on male biology,” she said in an interview with Falling Walls. “By applying genomics and AI, we’re building much-needed biological references for female organs and transforming how we diagnose and understand reproductive ageing.”
Earlier this year, Angela Relógio (EMBL Heidelberg predoc, Kafatos/Valcarcel Groups, 1999–2006) was one of three for finalists for the Deutscher Gründerpreis 2025 for TimeTeller, the Hamburg-based health tech startup she co-founded to bring chronobiology into everyday medicine.
The company was the outright winner of the Hamburger Gründerpreis 2025.
TimeTeller’s diagnostic platform measures a patient’s internal biological time from a simple saliva test, using AI and molecular analysis to identify when the body is most receptive, or sensitive, to specific treatments.
“The company emerged from the work developed in my research group,” said Relógio, now Professor at the Charité – Universitätsmedizin Berlin. “If we want to bring a medical device to market, we can’t do it alone as researchers. It requires a company that meets the necessary certifications and regulatory requirements.”
Her company’s goal – to empower individuals and healthcare professionals with knowledge and tools to optimise health and prevent diseases through understanding and applying the power of circadian rhythms – marks a paradigm shift away from one-size-fits-all schedules toward treatment in sync with human biology.
The Falling Walls Foundation, inspired by the fall of the Berlin Wall, promotes collaboration across disciplines to advance scientific and social progress. The annual Falling Walls Science Summit in Berlin culminates on 9 November with the presentation of the Science Breakthroughs of the Year awards.
The Deutscher Gründerpreis is an annual German award recognising outstanding entrepreneurship. It aims to make successful founders and their businesses visible and, through a network of coaching, mentoring and media support, help them become even more successful.
Together, Gonçalves, Schuh, and Relógio typify how former EMBL researchers continue to shape public health outcomes — in their work, through science that challenges convention, prioritises women’s health, and personalises care for the future. Their recognition underscores the impact of the EMBL alumni community worldwide.
Have you or a fellow member of the EMBL alumni community recently been recognised for your work? Please contact the Alumni Relations Office.